SCHEMBL10028636

SCHEMBL10028636

C=S(=O)(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12134586 0.78
SCHEMBL13419273 0.78
Sulfuric Acid SCHEMBL28681208 0.75 CA5A (0.75)
SCHEMBL148135 0.75
Sulfuric Acid SCHEMBL28537753 0.75 CA5A (0.75)
Sulfuric Acid SCHEMBL562189 0.75
Sulfuric Acid SCHEMBL11255468 0.75 CA5A (0.75)
Sulfuric Acid SCHEMBL1396634 0.75
Sulfuric Acid SCHEMBL31435537 0.75 CA5A (0.75)
Sulfuric Acid SCHEMBL29131640 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016110560-A1 PROCESS OF PRODUCTION OF SPECIFIC ACETALS AND KETALS DSM IP ASSETS B.V. (NL) 2016-07-14 WO disclosed
US-20160106851-A1 Groundbreaking Platform Technology for Specific Binding to Necrotic Cells HQ MEDICAL NETHERLANDS B V (NL) 2016-04-21 US disclosed
US-9249156-B2 Phosphoinositide 3-kinase inhibitor with a zinc binding moiety CURIS, INC. (US) 2016-02-02 US disclosed
US-20150150844-A1 METHODS AND COMPOSITIONS FOR TREATING CANCER SUTTER BAY HOSPITALS 2015-06-04 US disclosed
US-20140243330-A1 PHOSPHOINOSITIDE 3-KINASE INHIBITOR WITH A ZINC BINDING MOIETY CURIS, INC. (US) 2014-08-28 US disclosed
US-20130011795-A1 FLUORINE-FREE FUSED RING HETEROAROMATIC PHOTOACID GENERATORS AND RESIST COMPOSITIONS CONTAINING THE SAME INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2013-01-10 US disclosed
US-20120165559-A1 Compounds Having a Physiological Effect V. MANE FILS (FR) 2012-06-28 US disclosed
US-20120003319-A9 COMPOSITIONS FOR SITE-SPECIFIC DELIVERY OF IMATINIB AND METHODS OF USE ELAN PHARMA INTERNATIONAL LIMITED (IE) 2012-01-05 US disclosed
WO-2011134280-A1 COMPOUNDS AS AGONISTS OF S1P1 RECEPTORS GLAXO GROUP LIMITED (GB) 2011-11-03 WO disclosed
US-20090238884-A1 COMPOSITIONS FOR SITE-SPECIFIC DELIVERY OF IMATINIB AND METHODS OF USE ELAN PHARMA INTERNATIONAL LIMITED (IE) 2009-09-24 US disclosed
US-20070142637-A1 Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug EGIS GYOGYSZERGYAR RT. (HU) 2007-06-21 US disclosed
US-20070117837-A1 Process for the preparation of amorphous form of a platelet aggregation inhibitor drug EGIS GYOGYSZERGYAR RT. (HU) 2007-05-24 US disclosed